AstraZeneca PLC
How to invest $100,000 when stocks are at all-time highs? Here’s what two wealth managers say
As stock markets press against all-time highs driven by the potential of artificial intelligence, the question of how to invest $100,000 has become more urgent than ever. To shed light on this, CNBC Pro asked two seasoned investment professionals — Richard Flax, chief investment officer at digital wealth manager Moneyfarm , and Robert Matthews, deputy […]
Read More
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! I’m back in New York City after spending the last weekend in […]
Read More
This up-and-coming cancer treatment could be a $25 billion market opportunity — it’s already a hotbed for M&A
Skynesher | E+ | Getty Images Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall Street are calling a “massive opportunity.” It’s called targeted radiopharmaceutical therapy. It essentially delivers radiation directly into tumors by attaching a radioactive particle to a targeting molecule. RBC Capital Markets sees a $25 […]
Read More
A corner of the cancer therapy market is heating up—Here are the names investors need to know
There’s been a lot of attention lately on a corner of the oncology market called radiopharmaceuticals. The therapy seeks to destroy cancer cells by binding a radioactive particle to a targeted molecule and then dispatching it directly into the tumor. There are currently two products on the market from Novartis and a slew of clinical […]
Read More
Stocks producing the greatest moves midday: Peloton, Lam Investigation, Lowe’s, AstraZeneca and extra
Test out the businesses making the greatest moves midday: Peloton — The stock plunged 14% subsequent the linked fitness firm’s announcement it will commence a “world wide refinancing” process that contains a convertible notes offering and a $1 billion five-calendar year expression loan. Peloton, which just lately declared a restructuring system , has struggled with […]
Read More
European markets lower as positive momentum fades
AstraZeneca is in its ‘post-Covid era’, CFO says AstraZeneca shares were 0.6% higher at 9:45 a.m. in London, after the company said it plans to increase its total revenue to $80 billion by 2030, up 75% from $45.8 billion in 2023. It will focus on its oncology, biopharmaceuticals and rare diseases businesses and expects to […]
Read More
AstraZeneca targets $80 billion in total revenue by 2030 in ‘post-Covid era’
The Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai, China, July 7, 2021. Costfoto | Future Publishing | Getty Images LONDON — Pharmaceutical company AstraZeneca on Tuesday said it planned to increase its total revenue to $80 billion by 2030 — up 75% from $45.8 billion in 2023. “We have […]
Read More
Pfizer and AstraZeneca announce new investments of practically $1 billion in France
Sopa Images | Lightrocket | Getty Photographs Major healthcare corporations Pfizer and AstraZeneca announced on Sunday new investments in France worthy of a whole of virtually $1 billion, ahead of the get started of this year’s yearly ‘Choose France’ small business summit. Pfizer reported it would devote 500 million euros ($538.5 million) in France to develop up […]
Read More
AstraZeneca to withdraw Covid vaccine worldwide, citing a drop in demand
In this photo illustration a covid-19 vaccine is seen with the AstraZeneca logo in the background. (Photo Illustration by Nikos Pekiaridis/NurPhoto via Getty Images) Nurphoto | Nurphoto | Getty Images Pharmaceutical giant AstraZeneca on Wednesday said it planned to withdraw its Covid-19 vaccine as demand for it has declined. The so-called Vaxzevria vaccine was developed […]
Read More
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly’s weight loss drug dominance
The injectable weight-loss medication Wegovy is available at New City Halstead Pharmacy on April 24, 2024 in Chicago, Illinois. Scott Olson | Getty Images Novo Nordisk and Eli Lilly have long dominated the rapidly growing weight loss drug market, but their duopoly is closer than ever to facing a threat from a new rival. Amgen […]
Read More